+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharming Group NV - logo

The Pharming Group offers novel platforms for the production of protein therapeutics, as well as processes for the purification and formulation. The company’s best known product is Ruconest, a human C1 inhibitor. Human C1 inhibitor is a protein involved in the regulation of the complement and contact pathways of the immune system. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1400 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1150 Pages
  • Global
From
From
From
From
From
From
From
From
Gaucher Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Gaucher Disease Treatment - Global Strategic Business Report

  • Report
  • December 2024
  • 194 Pages
  • Global
From
From
Acute Ischemic Stroke - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Ischemic Stroke - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 80 Pages
  • Global
From
Gaucher's Disease Global Market Report 2024 - Product Thumbnail Image

Gaucher's Disease Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Complement C1 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Complement C1 inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator